Rayce Biotechnology (Beijing) Co., Ltd

Rayce Biotechnology (Beijing) Co., Ltd specializes in the Dry Fluorescence Immunoassay Analyzer, a diagnostic device used for in vitro testing. This analyzer detects and quantifies specific biological analytes, such as hormones, infectious agents, or biomarkers, in clinical or research settings. The technology relies on fluorescence detection to provide automated, precise results with minimal user input.

The company is headquartered in China. While the specific location within China isn’t detailed, its primary operational base is in Beijing, where it develops and manufactures its medical devices.

The company’s Dry Fluorescence Immunoassay Analyzer is registered in the euamed database, which is the European Union’s official medical device registry. This listing indicates the device’s presence in the EU market, though its regulatory classification and compliance depend on the jurisdiction where it is sold.

The Dry Fluorescence Immunoassay Analyzer falls under Class A classification in the EU. This classification is determined by factors like the device’s risk level and intended use. Class A devices are generally considered low-risk, but compliance and authorization requirements still apply based on the specific regulatory framework of the country where the device is marketed.